The presence of precipitate found in Dobuject Injection 50mg/ml (Batch no: MA00X7F)

M.B.D. Marketing (S) Pte Ltd would like to update healthcare professionals regarding the presence of precipitation found in the Dobuject Injection from Batch MA00X7F. This precipitate is the crystallisation of dobutamine. The affected batch: MA00X7F, has thus been placed under quarantine. Investigation is ongoing to ascertain that the problem is confined to this batch. Healthcare professionals are strongly advised to visually inspect the Dobuject injection and ensure the absence of particulate matter before the administration of the product. Please refer to the letter for  more details.

 
 
Healthcare professional, Medical devices
Published:

Dear Healthcare Professional Letters

12 Dec 2019

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP). HPP is a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.hpp.moh.gov.sg/, and follow the procedures below to access the MOH Alert system.

Step 1: Scroll down to the bottom navigation panel of the HPP web page. Under the Healthcare Professionals section, expand the dropdown option for ‘Healthcare Professional Portal’ and select your profession. You will be redirected to the specific HPP web page to log in.

Step 2: Click on the Restricted Content icon on the left panel of the web page and log in via SingPass.

Step 3: Click on the MOH Alert icon under the ‘Applications’ section.

Step 4: Click on the Drug Alert tab to view the DHCPLs.